References
- Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50. https://doi.org/10.1016/j.diabres.2017.03.024
- Asociacion Espanola de Enfermeria Vascular y Heridas (AEEVH). Guia de practica clinica: consenso sobre ulceras vasculares y pie diabetico. Segunda edicion. Seville, Asociacion Espanola de Enfermeria Vascular y Heridas. 2014. pp 1-90.
- Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-62. https://doi.org/10.2337/diacare.28.4.956
- Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-23, e67-e88. https://doi.org/10.1111/j.1468-1331.2010.02999.x
- Stein C, Eibel B, Sbruzzi G, Lago PD, Plentz RD. Electrical stimulation and electromagnetic field use in patients with diabetic neuropathy: systematic review and meta-analysis. Braz J Phys Ther 2013; 17: 93-104. https://doi.org/10.1590/S1413-35552012005000083
- Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 2015; 6: 432-44. https://doi.org/10.4239/wjd.v6.i3.432
- Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American academy of neurology, the American association of neuromuscular and electrodiagnostic medicine, and the American academy of physical medicine and rehabilitation. Neurology 2011; 76: 1758-65. https://doi.org/10.1212/WNL.0b013e3182166ebe
- Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain 2010; 23: 99-108. https://doi.org/10.3344/kjp.2010.23.2.99
- Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther 2009; 89: 873-80.
- Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. https://doi.org/10.1016/0197-2456(95)00134-4
- Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928. https://doi.org/10.1136/bmj.d5928
- Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] [Internet]. London, The Cochrane Collaboration. 2011 [cited 2018 March 3]. Available at http://handbook-5-1.cochrane.org/.
- Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109-18. https://doi.org/10.1016/j.pain.2005.03.029
- Niesters M, Proto PL, Aarts L, Sarton EY, Drewes AM, Dahan A. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth 2014; 113: 148-56. https://doi.org/10.1093/bja/aeu056
- Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebocontrolled trial. J Pain 2005; 6: 253-60. https://doi.org/10.1016/j.jpain.2004.12.007
- Campbell CM, Kipnes MS, Stouch BC, Brady KL, Kelly M, Schmidt WK, et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012; 153: 1815-23. https://doi.org/10.1016/j.pain.2012.04.014
- Rauck R, Makumi CW, Schwartz S, Graff O, Meno-Tetang G, Bell CF, et al. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy. Pain Pract 2013; 13: 485-96. https://doi.org/10.1111/papr.12014
- Weintraub MI, Herrmann DN, Smith AG, Backonja MM, Cole SP. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil 2009; 90: 1102-9. https://doi.org/10.1016/j.apmr.2009.01.019
- Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebocontrolled trial. Arch Phys Med Rehabil 2003; 84: 736-46. https://doi.org/10.1016/S0003-9993(03)00106-0
- Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, et al. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study. Clin Ther 2005; 27: 1420-31. https://doi.org/10.1016/j.clinthera.2005.09.011
- Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial. Pain Pract 2013; 13: 497-503. https://doi.org/10.1111/papr.12013
- National Institute for Health and Care Excellence (NICE). Neuropathic pain in adults: the pharmacological management of neuropathic pain in adults in non-specialist settings. NICE clinical guideline. London, National Institute for Health and Care Excellence. 2013.
- Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 162-73. https://doi.org/10.1016/S1474-4422(14)70251-0
Cited by
- Perioperative duloxetine as part of a multimodal analgesia regime reduces postoperative pain in lumbar canal stenosis surgery: a randomized, triple blind, and placebo-controlled trial vol.33, pp.1, 2020, https://doi.org/10.3344/kjp.2020.33.1.40
- Komplexe Behandlungsprinzipien in der orthopädischen Rheumatologie vol.16, pp.5, 2018, https://doi.org/10.1055/a-1390-9842